Oral administration of an integrative supplement (CogniCaps®) improves cognitive scores in aging dogs with canine cognitive dysfunction for at least two months: An open-label investigation in 10 dogs
- PMID: 37073246
- PMCID: PMC10105794
- DOI: 10.5455/OVJ.2023.v13.i2.6
Oral administration of an integrative supplement (CogniCaps®) improves cognitive scores in aging dogs with canine cognitive dysfunction for at least two months: An open-label investigation in 10 dogs
Abstract
Background: Canine cognitive dysfunction (CCD), the dog analog of human Alzheimer's disease (AD), is a progressive neurodegenerative condition that presents many treatment challenges. There are few effective drugs with acceptable side effects for AD/CCD, which has prompted investigation into non-drug options, collectively termed nutraceuticals. Nutraceutical supplements are conceptually divided into conventional (Western) and non-conventional (Eastern) ingredients. Many of these individual supplements have shown in vitro and/or in vivo efficacy in ameliorating neuronal damage in rodent models, and some have demonstrated positive effects on cognition in rodent models and clinical trials in dogs and humans with cognitive impairment.
Aim: The purpose of this open-label clinical trial was to investigate the effect of an oral integrative (combination of conventional nutraceuticals and Chinese herbals) supplement (CogniCaps®) on cognitive scores when administered to aging dogs with CCD over a 2-month period.
Methods: Ten aging (>9-year-old) dogs with moderate (16-33) cognitive scores were recruited and administered oral CogniCaps® for two months. No additional drugs or nutraceuticals directed at improving cognitive function were allowed during the study period. Baseline cognitive scores were compared with those procured at 30 and 60 days. Cognitive scores for baseline, 30- and 60-days post-treatment were compared.
Results: Cognitive scores improved at 30 days (38% reduction) and 60 days (41% reduction) post-treatment (p = 0.002). Scores did not differ between 30- and 60-day assessments (p = 0.7).
Conclusion: The results of this small preliminary study suggest that the integrative supplement CogniCaps® might improve cognitive scores in dogs with CCD within the first 30 days of administration and that this improvement is sustained at 60-day follow up.
Keywords: Alzheimer’s; Canine; Cognitive; Integrative; Supplement.
Conflict of interest statement
Dr. Dewey formulated CogniCaps® and receives a percentage of sales.
Figures
Similar articles
-
Transcranial photobiomodulation therapy improves cognitive test scores in dogs with presumptive canine cognitive dysfunction: A case series of five dogs.Open Vet J. 2024 May;14(5):1167-1171. doi: 10.5455/OVJ.2024.v14.i5.11. Epub 2024 May 31. Open Vet J. 2024. PMID: 38938435 Free PMC article.
-
Periodontal disease is associated with cognitive dysfunction in aging dogs: A blinded prospective comparison of visual periodontal and cognitive questionnaire scores.Open Vet J. 2021 Apr-Jun;11(2):210-216. doi: 10.5455/OVJ.2021.v11.i2.4. Epub 2021 Apr 19. Open Vet J. 2021. PMID: 34307077 Free PMC article.
-
Poop for thought: Can fecal microbiome transplantation improve cognitive function in aging dogs?Open Vet J. 2025 Feb;15(2):556-564. doi: 10.5455/OVJ.2025.v15.i2.6. Epub 2025 Feb 28. Open Vet J. 2025. PMID: 40201831 Free PMC article. Review.
-
Associations between physical activity and cognitive dysfunction in older companion dogs: results from the Dog Aging Project.Geroscience. 2023 Apr;45(2):645-661. doi: 10.1007/s11357-022-00655-8. Epub 2022 Sep 21. Geroscience. 2023. PMID: 36129565 Free PMC article.
-
Transcranial photobiomodulation (laser) therapy for cognitive impairment: A review of molecular mechanisms and potential application to canine cognitive dysfunction (CCD).Open Vet J. 2022 Mar-Apr;12(2):256-263. doi: 10.5455/OVJ.2022.v12.i2.14. Epub 2022 Apr 17. Open Vet J. 2022. PMID: 35603072 Free PMC article. Review.
Cited by
-
Enhancing cognitive functions in aged dogs and cats: a systematic review of enriched diets and nutraceuticals.Geroscience. 2025 Jun;47(3):2925-2947. doi: 10.1007/s11357-025-01521-z. Epub 2025 Jan 18. Geroscience. 2025. PMID: 39827310 Free PMC article.
References
-
- Bednarikova Z, Gancar M, Wang R, Zheng L, Tang Y, Luo Y, Huang Y, Spodniakova B, Ma L, Gazova Z. Extracts from Chinese herbs with anti-amyloid and neuroprotective activities. Int. J. Biol. Macromol. 2021;179:475–484. - PubMed
-
- Dewey C.W, Davies E.S, Xie H, Wakshlag J.J. Canine cognitive dysfunction: pathophysiology, diagnosis, and treatment. Vet. Clin. North Am. Small Anim. Pract. 2019;49:477–499. - PubMed
-
- Gonzalez-Martinez A, Rosado B, Pesini P, Garcia-Belenguer S, Palacio J, Villegas A, Suarez M.L, Santamarina G, Sarasa M. Effect of age and severity of cognitive dysfunction on two simple tasks in pet dogs. Vet. J. 2013;198(1):176–181. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical